4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000045
Chief Executive Officer sold 15,271 shares at $13.52 ($206,433)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2024-10-11 | Sale 10b5-1 | −15,271 | $13.52 | $206,433 | 895,941 | D |
| Open-market sales · 15,271 sh · avg $13.52 · $206,433 | |||||||
Loading xslF345X05/wk-form4_1729023711.xml…